Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer
2023 · European Archives of Oto-Rhino-Laryngology · 30 citations
https://doi.org/10.1007/s00405-023-07827-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
147
Papers
3.3K
Citations
31
h-index
52
i10-index
Elisabeth Maurer is an academic researcher from Philipps University of Marburg. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Thyroid Cancer Diagnosis and Treatment & Cystic Fibrosis Research Advances. The author has an h-index of 31, co-authored 125 publications.
ORCID: 0000-0003-3431-6233https://doi.org/10.1007/s00405-023-07827-y
https://doi.org/10.1016/j.atherosclerosis.2019.01.004
Click to start Chat